Endovia Health Sciences (EDVA) Share-based Compensation (2019 - 2026)
Powered by 
Analysis
Endovia Health Sciences (EDVA) Share-based Compensation (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.50 Bn | 133.65 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 65.05 Bn | 59.86 Bn | 1.37 Bn | 4.00 Mn |
| 4 | Moderna | 57.11 Bn | 51.98 Bn | 52.00 Mn | 120.00 Mn |
| 5 | Revolution Medicines | 44.71 Bn | 44.71 Bn | - | 277.20 Mn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 137.41 Mn |
| 7 | Alnylam Pharmaceuticals | 35.36 Bn | 32.05 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Royalty Pharma | 28.16 Bn | 27.32 Bn | - | - |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Endovia Health Sciences | 801,166.21 | 558,464.21 | - | 1.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.11 Mn |
| Mar 31, 2026 | 176,972.00 |
| Dec 31, 2025 | 564,729.00 |
| Sep 30, 2025 | 7.75 Mn |
| Jun 30, 2025 | 53,859.00 |
| Mar 31, 2025 | 140,762.00 |
| Dec 31, 2024 | 264,811.00 |
| Sep 30, 2024 | 186,682.00 |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 556,672.00 |
| Dec 31, 2023 | -54,243.00 |
| Sep 30, 2023 | 143,578.00 |
| Jun 30, 2023 | 864,763.00 |
| Mar 31, 2023 | 215,760.00 |
| Dec 31, 2022 | 210,397.00 |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | 2.72 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | -2.25 Mn |
| Sep 30, 2021 | 17.32 Mn |